This study is the first evidence that treatment with diclofenac increased the radiosensitivity of prostate cancer cells by suppression of COX-2 up-regulation and induction of TRAIL in vitro, and that topical treatment with diclofenac gel enhanced antitumor potential of RT in vivo. Here, TNFSF10 is linked to prostate cancer.